Morrison & Foerster is pleased to sponsor the Third Annual ChinaBio BioBay Investor Forum to be held in Suzhou, China.  The event will explore the state of China’s rapidly growing life sciences industry and the financial drivers that will determine its success.  Peng Chen will be a speaker on the Drugs – Novel vs. Generics panel to be held on November 3, 2010 from 10:00 – 11:00 am. 

Other speakers include:

• David Xu, PhD, MBA
  Managing Partner, Mingly China Growth Fund 
• Leon Chen, PhD
  Partner, Fidelity Asia Ventures 
• Li Chen, PhD
  President & CEO, Hua Medicine
• Jennifer Hu, PhD
  Director of Licensing & External Research, Merck & Co., Inc., USA
• Peter (Peizhi) Luo, PhD
  Founder & Chairman, Adagene Inc.

For more information about the event, please visit the conference website here.